Whole-exome sequencing reveals recurrent somatic mutation networks in cancer

Cancer Letters

Volumn 340, Issue 2, 2013, Pages 270-276

  Liu, Xiaoping ^a   Wang, Jiguang ^b,d   Chen, Luonan ^a,c  

^a Chinese Academy of Sciences   (China)

^b Chinese Academy of Sciences   (China)

^c INSTITUTE OF INDUSTRIAL SCIENCE   (Japan)

^d NONE   (United States)

Author keywords

Cancer; Somatic mutation network; Whole exome sequencing

Indexed keywords

DNA FRAGMENT; GENOMIC DNA;

BASE PAIRING; CANCER GROWTH; CARCINOGENESIS; DISEASE COURSE; EXOME; EXON; GENE MUTATION; GENE SEQUENCE; HIGH THROUGHPUT SEQUENCING; MOLECULAR MECHANICS; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

EID: 84887616489     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.11.002     Document Type: Review

References (67)

1. Macgregor P.F., Squire J.A. Application of microarrays to the analysis of gene expression in cancer. Clin. Chem. 2002, 48:1170-1177.
2. Wang Y., Tetko I.V., Hall M.A., Frank E., Facius A., et al. Gene selection from microarray data for cancer classification - a machine learning approach. Comput. Biol. Chem. 2005, 29:37-46.
3. Albertson D.G., Pinkel D. Genomic microarrays in human genetic disease and cancer. Hum. Mol. Genet. 2003, 12:R145-R152. Spec No. 2.
4. Sorensen K.D., Orntoft T.F. Discovery of prostate cancer biomarkers by microarray gene expression profiling. Expert Rev. Mol. Diagn. 2010, 10:49-64.
5. Cui J., Chen Y., Chou W.C., Sun L., Chen L., et al. An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic Acids Res. 2011, 39:1197-1207.
6. Liu X., Liu Z.P., Zhao X.M., Chen L. Identifying disease genes and module biomarkers by differential interactions. J. Am. Med. Inform. Assoc. 2012, 19:241-248.
7. Meyerson M., Gabriel S., Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. 2010, 11:685-696.
8. Weir B., Zhao X., Meyerson M. Somatic alterations in the human cancer genome. Cancer Cell 2004, 6:433-438.
9. Barbieri C.E., Baca S.C., Lawrence M.S., Demichelis F., Blattner M., et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 2012, 44:685-689.
10. Quesada V., Conde L., Villamor N., Ordonez G.R., Jares P., et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat. Genet. 2012, 44:47-52.
11. Yan X.J., Xu J., Gu Z.H., Pan C.M., Lu G., et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat. Genet. 2011, 43:309-315.
12. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
13. Ng S.B., Buckingham K.J., Lee C., Bigham A.W., Tabor H.K., et al. Exome sequencing identifies the cause of a Mendelian disorder. Nat. Genet. 2010, 42:30-35.
14. Agrawal N., Frederick M.J., Pickering C.R., Bettegowda C., Chang K., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333:1154-1157.
15. Ong C.K., Subimerb C., Pairojkul C., Wongkham S., Cutcutache I., et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat. Genet. 2012, 44:690-693.
16. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615.
17. Ng S.B., Turner E.H., Robertson P.D., Flygare S.D., Bigham A.W., et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009, 461:272-276.
18. Bainbridge M.N., Wang M., Burgess D.L., Kovar C., Rodesch M.J., et al. Whole exome capture in solution with 3Gbp of data. Genome Biol. 2010, 11:R62.
19. Pettersson E., Lundeberg J., Ahmadian A. Generations of sequencing technologies. Genomics 2009, 93:105-111.
20. Cerami E., Demir E., Schultz N., Taylor B.S., Sander C. Automated network analysis identifies core pathways in glioblastoma. PLoS ONE 2010, 5:e8918.
21. Torkamani A., Schork N.J. Identification of rare cancer driver mutations by network reconstruction. Genome Res. 2009, 19:1570-1578.
22. Ciriello G., Cerami E., Sander C., Schultz N. Mutual exclusivity analysis identifies oncogenic network modules. Genome Res. 2012, 22:398-406.
23. Miller C.A., Settle S.H., Sulman E.P., Aldape K.D., Milosavljevic A. Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors. BMC Med. Genom. 2011, 4:34.
24. Teer J.K., Mullikin J.C. Exome sequencing: the sweet spot before whole genomes. Hum. Mol. Genet. 2010, 19:R145-R151.
25. Albert T.J., Molla M.N., Muzny D.M., Nazareth L., Wheeler D., et al. Direct selection of human genomic loci by microarray hybridization. Nat. Methods 2007, 4:903-905.
26. Okou D.T., Steinberg K.M., Middle C., Cutler D.J., Albert T.J., et al. Microarray-based genomic selection for high-throughput resequencing. Nat. Methods 2007, 4:907-909.
27. Hodges E., Xuan Z., Balija V., Kramer M., Molla M.N., et al. Genome-wide in situ exon capture for selective resequencing. Nat. Genet. 2007, 39:1522-1527.
28. Hodges E., Rooks M., Xuan Z., Bhattacharjee A., Benjamin Gordon D. Hybrid selection of discrete genomic intervals on custom-designed microarrays for massively parallel sequencing. Nat. Protoc. 2009, 4:960-974.
29. Herman D.S., Hovingh G.K., Iartchouk O., Rehm H.L., Kucherlapati R., et al. Filter-based hybridization capture of subgenomes enables resequencing and copy-number detection. Nat. Methods 2009, 6:507-510.
30. Summerer D., Wu H., Haase B., Cheng Y., Schracke N., et al. Microarray-based multicycle-enrichment of genomic subsets for targeted next-generation sequencing. Genome Res. 2009, 19:1616-1621.
31. Kahvejian A., Quackenbush J., Thompson J.F. What would you do if you could sequence everything?. Nat. Biotechnol. 2008, 26:1125-1133.
32. Gnirke A., Melnikov A., Maguire J., Rogov P., LeProust E.M., et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat. Biotechnol. 2009, 27:182-189.
33. Mamanova L., Coffey A.J., Scott C.E., Kozarewa I., Turner E.H., et al. Target-enrichment strategies for next-generation sequencing. Nat. Methods 2010, 7:111-118.
34. Li J.B., Gao Y., Aach J., Zhang K., Kryukov G.V., et al. Multiplex padlock targeted sequencing reveals human hypermutable CpG variations. Genome Res. 2009, 19:1606-1615.
35. Porreca G.J., Zhang K., Li J.B., Xie B., Austin D., et al. Multiplex amplification of large sets of human exons. Nat. Methods 2007, 4:931-936.
36. Turner E.H., Lee C., Ng S.B., Nickerson D.A., Shendure J. Massively parallel exon capture and library-free resequencing across 16 genomes. Nat. Methods 2009, 6:315-316.
37. Ji H., Welch K. Molecular inversion probe assay for allelic quantitation. Methods Mol. Biol. 2009, 556:67-87.
38. Wang Y., Moorhead M., Karlin-Neumann G., Wang N.J., Ireland J., et al. Analysis of molecular inversion probe performance for allele copy number determination. Genome Biol. 2007, 8:R246.
39. Briggs A.W., Good J.M., Green R.E., Krause J., Maricic T., et al. Targeted retrieval and analysis of five Neandertal mtDNA genomes. Science 2009, 325:318-321.
40. Briggs A.W., Good J.M., Green R.E., Krause J., Maricic T., et al. Primer extension capture: targeted sequence retrieval from heavily degraded DNA sources. J. Vis. Exp. 2009, 1573.
41. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., et al. The sequence alignment/map format and SAMtools. Bioinformatics 2009, 25:2078-2079.
42. McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010, 20:1297-1303.
43. Koboldt D.C., Chen K., Wylie T., Larson D.E., McLellan M.D., et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 2009, 25:2283-2285.
44. Navin N., Krasnitz A., Rodgers L., Cook K., Meth J., et al. Inferring tumor progression from genomic heterogeneity. Genome Res. 2010, 20:68-80.
45. Carter S.L., Cibulskis K., Helman E., McKenna A., Shen H., et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 2012, 30:413-421.
46. Li H., Ruan J., Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 2008, 18:1851-1858.
47. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10:R25.
48. Goya R., Sun M.G., Morin R.D., Leung G., Ha G., et al. SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics 2010, 26:730-736.
49. Roth A., Ding J., Morin R., Crisan A., Ha G., et al. JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics 2012, 28:907-913.
50. Larson D.E., Harris C.C., Chen K., Koboldt D.C., Abbott T.E., et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics 2012, 28:311-317.
51. Koboldt D.C., Zhang Q., Larson D.E., Shen D., McLellan M.D., et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012, 22:568-576.
52. Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008, 456:66-72.
53. Mardis E.R., Ding L., Dooling D.J., Larson D.E., McLellan M.D., et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 2009, 361:1058-1066.
54. Heppner G.H. Tumor heterogeneity. Cancer Res. 1984, 44:2259-2265.
55. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
56. Kaminker J.S., Zhang Y., Watanabe C., Zhang Z. CanPredict: a computational tool for predicting cancer-associated missense mutations. Nucleic Acids Res. 2007, 35:W595-W598.
57. Carter H., Chen S., Isik L., Tyekucheva S., Velculescu V.E., et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res. 2009, 69:6660-6667.
58. Velculescu V.E. Defining the blueprint of the cancer genome. Carcinogenesis 2008, 29:1087-1091.
59. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458:719-724.
60. Boca S.M., Kinzler K.W., Velculescu V.E., Vogelstein B., Parmigiani G. Patient-oriented gene set analysis for cancer mutation data. Genome Biol. 2010, 11:R112.
61. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812.
62. Lin J., Gan C.M., Zhang X., Jones S., Sjoblom T., et al. A multidimensional analysis of genes mutated in breast and colorectal cancers. Genome Res. 2007, 17:1304-1318.
63. Vandin F., Upfal E., Raphael B.J. De novo discovery of mutated driver pathways in cancer. Genome Res. 2012, 22:375-385.
64. He D., Liu Z., Honda M., Kaneko S., Chen L. Coexpression network analysis in chronic hepatitis B and C hepatic lesion reveals distinct patterns of disease progression to hepatocellular carcinoma. J. Mol. Cell Biol. 2012, 4(3):140-152.
65. Wen Z., Liu Z., Liu Z., Zhang Y., Chen L. An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer. J. Am. Med. Inform. Assoc. 2012, 10.1136/amiajnl-2012-001168.
66. Chen L., Liu R., Liu Z., Li M., Aihara K. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci. Rep. 2012, 2:342. 10.1038/srep0034.
67. Liu R., Li M., Liu Z., Wu J., Chen L., Aihara K. Identifying critical transitions and their leading networks in complex diseases. Sci. Rep. 2012, 2:813. 10.1038/srep00813.